Advertisement

Latest News

Continuous Ketone Monitoring in Diabetes: Clinical Potential and Future Impact, With Rodolfo Galindo, MD

44 minutes ago

Galindo describes how CKM may transform diabetes care by enabling real-time insights, improving DKA prevention, and advancing metabolic understanding.

FDA Approves Lunsotogene Parvec for OTOF-Related Genetic Hearing Loss

3 hours ago

FDA approved lunsotogene parvec for OTOF-related hearing loss based on phase 1/2 data showing improved hearing in a small cohort.

GLP-1 RAs Improve End-Organ Complications in Patients With Type 1 Diabetes

5 hours ago

Recent data presented at AACE 2026 have indicated the efficacy of GLP-1 RA treatment in reducing risk of diabetic retinopathy, renal disease, and others.

Guidance for Clinicians on Patient Questions About Psychedelics, With Gus Alva, MD

5 hours ago

Alva outlines how general clinicians should address patient questions on psychedelic therapies, including risks, approvals, and referral pathways.

Patient Awareness of Dermatologic Conditions Using AI, With Rory Sayres, PhD, and Yun Liu, PhD

6 hours ago

Liu and Sayres emphasize that while AI tools improve consumer recognition of skin conditions, gaps remain in prediction accuracy and information.

Advertisement
Advertisement